Clinical Trial Update: Molecular Profiling of Advanced Soft-tissue Sarcomas [Phase 3]

View source ↗

Summary

Phase 3 trial assessing molecular profiling in advanced soft-tissue sarcomas has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Snippet

Sponsor: Institut National de la Santé Et de la Recherche Médicale, France | Conditions: Soft Tissue Sarcoma | Phase 3 | Status: COMPLETED